Docebo Inc.

TSX:DCBO Stok Raporu

Piyasa değeri: CA$784.4m

Docebo Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Docebo kazanç ve gelirin sırasıyla yıllık 11.9% ve 10.2% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 15.4% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 40.4% olacağı tahmin edilmektedir.

Anahtar bilgiler

11.9%

Kazanç büyüme oranı

15.41%

EPS büyüme oranı

Software kazanç büyümesi21.8%
Gelir büyüme oranı10.2%
Gelecekteki özkaynak getirisi40.39%
Analist kapsamı

Good

Son güncelleme05 May 2026

Gelecekteki son büyüme güncellemeleri

Recent updates

Analiz Güncellemesi Apr 26

DCBO: Buyback And Strong Bookings Are Expected To Reward Patience

Narrative Update: Docebo Analyst Target Shift The updated fair value estimate for Docebo edges higher to CA$36.09 from CA$35.10. This reflects analysts' recent target cuts in the CA$25 to CA$28 range, while still crediting the company with solid gross bookings and a healthier underlying business than headline metrics suggest.
Analiz Güncellemesi Apr 07

DCBO: Buybacks And Solid Bookings Are Expected To Support Upside Repricing

Narrative update Analysts have trimmed their average price targets on Docebo, with recent cuts such as Scotiabank moving to CA$25 from CA$32, Morgan Stanley to CA$26 from CA$28, and Stifel to CA$28 from CA$34. These revisions reflect expectations for softer near-term organic subscription growth and contract headwinds, even as analysts point to solid gross bookings and a core business that appears healthier than the headline metrics suggest.
Analiz Güncellemesi Mar 24

DCBO: Buybacks And Bookings Strength Will Support Future Upside Repricing

Analysts have reset expectations on Docebo, with several firms trimming their price targets into a CA$25 to CA$28 range. They cited softer near term organic subscription growth, headwinds from the AWS contract roll off and Dayforce churn, and a need to see more proof around execution despite recent strength in gross bookings.
Analiz Güncellemesi Mar 08

DCBO: Buybacks And Margin Expansion Will Support Future Upside Repricing

Analysts have lowered their price targets on Docebo, and our fair value estimate has been revised from about CA$42.80 to roughly CA$35.10. This adjustment reflects expectations of softer subscription growth, contract headwinds and a lower assumed future P/E multiple, partially offset by stronger modeled profit margins.
Analiz Güncellemesi Feb 22

DCBO: Rebased Earnings Profile And Buybacks Will Support Future Upside Repricing

Analysts have trimmed their average Docebo price target by about CA$0.34, reflecting slightly updated assumptions on discount rate, revenue growth, profit margins and future P/E multiples, while still viewing the core earnings profile as intact. Analyst Commentary Recent research updates on Docebo point to more cautious pricing assumptions, even as analysts broadly see the core business model as unchanged.
Analiz Güncellemesi Feb 07

DCBO: Rebased Profitability Assumptions Will Support Future Upside Repricing

Analysts have trimmed their price targets on Docebo, with our fair value estimate moving from about US$46.46 to US$43.15 as they factor in slightly lower profit margin assumptions, a marginally higher discount rate, and updated P/E expectations following recent target cuts at several firms. Analyst Commentary Recent research on Docebo has centered on valuation reset rather than ratings changes, with several firms revising their price targets lower and aligning expectations with updated P/E assumptions and discount rates.
Analiz Güncellemesi Jan 24

DCBO: Upmarket Enterprise Wins And Higher ARPU Will Drive Future Upside

Narrative Update The updated analyst price target for Docebo has moved lower to around $46.46 from about $49.45, as analysts factor in reduced Street targets, including cuts from firms that still highlight the company’s role in learning management systems and see revenue growth, margin outlook, and a lower future P/E as key parts of the risk-reward trade-off. Analyst Commentary Recent research on Docebo reflects a mix of optimism about the business model and caution around valuation and execution.
Analiz Makalesi Jan 15

Investors Shouldn't Overlook Docebo's (TSE:DCBO) Impressive Returns On Capital

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...
Analiz Güncellemesi Jan 08

DCBO: Enterprise Expansion And Higher ARPU Will Support Long-Term Upside

Analysts have adjusted their view on Docebo after a mix of recent research, including a price target cut to US$28 from US$34 and a fresh US$35 target at another firm. This has led to a small tweak in the modeled discount rate and future P/E multiple in our updated assumptions.
Analiz Güncellemesi Dec 24

DCBO: Enterprise Expansion Will Drive Long-Term Returns Despite Near-Term Margin Pressure

Analysts have trimmed their price target on Docebo to $28 from $34, reflecting slightly lower fair value and profit margin assumptions, even as they highlight the company’s strong learning management platform, upmarket expansion, and enterprise focused growth strategy. Analyst Commentary Recent Street research presents a mixed but generally constructive view on Docebo, with targets and ratings reflecting both confidence in the company’s long term growth profile and caution around near term execution and profitability.
Analiz Güncellemesi Dec 09

DCBO: Enterprise Focus And Upmarket Expansion Will Drive Long-Term Returns

Analysts have modestly reduced their price targets on Docebo, trimming expectations by mid single digits in dollar terms to reflect a slightly higher discount rate, while still highlighting the company’s strong competitive position, enterprise focus, and above market growth trajectory in learning management systems. Analyst Commentary Recent Street research on Docebo reflects a mix of optimism on the company’s long term growth profile and caution around near term valuation and execution risks.
Analiz Makalesi Nov 27

Docebo Inc.'s (TSE:DCBO) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors

Unfortunately for some shareholders, the Docebo Inc. ( TSE:DCBO ) share price has dived 26% in the last thirty days...
Analiz Güncellemesi Nov 25

DCBO: Enterprise Expansion And Upmarket Momentum Will Drive Future Returns

Analysts have recently lowered their average price target for Docebo, citing adjustments to profit margin expectations and valuation multiples. Figures have shifted from $34 to a range between $28 and $37 per share, reflecting evolving views on revenue growth and sector performance.
Analiz Güncellemesi Nov 11

DCBO: Enterprise Expansion And Improving Margins Will Drive Future Gains

Analysts have lowered their average price target for Docebo from $55.02 to $49.81. They cite cautious outlooks on growth rates and valuation multiples, despite continued optimism about the company’s profit margins and enterprise expansion strategy.
Analiz Güncellemesi Sep 04

AI Adoption And FedRAMP Certification Will Widen Market Opportunities

Despite an unchanged analyst price target for Docebo, the sharp rise in its future P/E ratio suggests heightened growth expectations are being offset by valuation concerns, resulting in no adjustment to its fair value at CA$55.02. What's in the News Docebo provided earnings guidance for Q3 2025, expecting total revenue between $61.0 million and $61.2 million.
Analiz Makalesi Jul 19

Here's Why We Think Docebo (TSE:DCBO) Might Deserve Your Attention Today

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analiz Makalesi Apr 29

An Intrinsic Calculation For Docebo Inc. (TSE:DCBO) Suggests It's 44% Undervalued

Key Insights Using the 2 Stage Free Cash Flow to Equity, Docebo fair value estimate is CA$78.13 Docebo's CA$43.74 share...
Analiz Makalesi Mar 08

Some Docebo Inc. (TSE:DCBO) Shareholders Look For Exit As Shares Take 27% Pounding

To the annoyance of some shareholders, Docebo Inc. ( TSE:DCBO ) shares are down a considerable 27% in the last month...
User avatar
Yeni Analiz Feb 06

Partnerships With Accenture And Deloitte Will Expand Global Market Presence

Strategic international expansion and partnerships, particularly in Europe, highlight potential revenue growth by diversifying geographic and market strategies.
Analiz Makalesi Jan 13

Is There Now An Opportunity In Docebo Inc. (TSE:DCBO)?

Docebo Inc. ( TSE:DCBO ), might not be a large cap stock, but it saw significant share price movement during recent...
Analiz Makalesi Dec 16

Docebo Inc. (TSE:DCBO) Investors Are Less Pessimistic Than Expected

Docebo Inc.'s ( TSE:DCBO ) price-to-sales (or "P/S") ratio of 7.3x may look like a poor investment opportunity when you...
Analiz Makalesi Nov 05

Investors Should Be Encouraged By Docebo's (TSE:DCBO) Returns On Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Analiz Makalesi Apr 30

What Does Docebo Inc.'s (TSE:DCBO) Share Price Indicate?

Docebo Inc. ( TSE:DCBO ), is not the largest company out there, but it saw a decent share price growth of 12% on the...
Analiz Makalesi Apr 15

Docebo (TSE:DCBO) Is Looking To Continue Growing Its Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'll want to see a proven...
Analiz Makalesi Mar 12

Calculating The Intrinsic Value Of Docebo Inc. (TSE:DCBO)

Key Insights The projected fair value for Docebo is CA$66.09 based on 2 Stage Free Cash Flow to Equity Docebo's...
Analiz Makalesi Feb 26

Docebo Inc.'s (TSE:DCBO) Price In Tune With Revenues

Docebo Inc.'s ( TSE:DCBO ) price-to-sales (or "P/S") ratio of 9x might make it look like a strong sell right now...
Analiz Makalesi Dec 04

Returns On Capital Are Showing Encouraging Signs At Docebo (TSE:DCBO)

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Analiz Makalesi Nov 04

An Intrinsic Calculation For Docebo Inc. (TSE:DCBO) Suggests It's 37% Undervalued

Key Insights Using the 2 Stage Free Cash Flow to Equity, Docebo fair value estimate is CA$94.71 Docebo's CA$59.50 share...
Analiz Makalesi Oct 01

Getting In Cheap On Docebo Inc. (TSE:DCBO) Might Be Difficult

When close to half the companies in the Software industry in Canada have price-to-sales ratios (or "P/S") below 3.1x...

Kazanç ve Gelir Büyüme Tahminleri

TSX:DCBO - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/202833160N/AN/A3
12/31/202730145575711
12/31/202627236474812
12/31/2025243382728N/A
9/30/2025237232829N/A
6/30/2025231212728N/A
3/31/2025223232729N/A
12/31/2024217272829N/A
9/30/2024209182526N/A
6/30/2024200172728N/A
3/31/202419172627N/A
12/31/202318131516N/A
9/30/202317111112N/A
6/30/2023161766N/A
3/31/20231521512N/A
12/31/2022143712N/A
9/30/20221344-10N/A
6/30/2022124-6-3-1N/A
3/31/2022115-15-4-3N/A
12/31/2021104-14-4-3N/A
9/30/202193-1623N/A
6/30/202182-1834N/A
3/31/202171-1445N/A
12/31/202063-845N/A
9/30/202056-7-6-5N/A
6/30/202051-10-8-8N/A
3/31/202046-9-7-7N/A
12/31/201941-12-5-5N/A
9/30/201937-12N/A-1N/A
6/30/201934-10N/A0N/A
3/31/201930-11N/A-2N/A
12/31/201827-11N/A-2N/A
12/31/201717-7N/A-3N/A
12/31/201610-3N/A-1N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: DCBO 'nin tahmini kazanç büyümesi (yıllık 11.9% ) tasarruf oranının ( 3% ) üzerindedir.

Kazançlar ve Piyasa: DCBO şirketinin kazançlarının (yıllık 11.9% ) Canadian pazarından (yıllık 11% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: DCBO şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: DCBO şirketinin gelirinin (yıllık 10.2% ) Canadian pazarından (yıllık 4.8% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: DCBO şirketinin gelirinin (yıllık 10.2% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: DCBO 'nin Özsermaye Getirisi'nin 3 yıl içinde çok yüksek olması tahmin ediliyor ( 40.4 %).


Büyüyen şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/05/07 09:39
Gün Sonu Hisse Fiyatı2026/05/07 00:00
Kazançlar2025/12/31
Yıllık Kazançlar2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Docebo Inc. 17 Bu analistlerden 12, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Martin TonerATB Cormark
Phillip LeytesBerenberg
Robert YoungCanaccord Genuity